Overview

The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers

Status:
TERMINATED

Trial end date:
2024-02-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.

Phase:

PHASE1

Details

Lead Sponsor:

Bugworks Research Inc.

Collaborator:

Avance Clinical Pty Ltd.